HEADER CHAPERONE 08-FEB-06 2FYP TITLE GRP94 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, RESIDUES (69-337); COMPND 5 SYNONYM: 94 KDA GLUCOSE-REGULATED PROTEIN, GRP94; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEX-NB-GRP94 KEYWDS GRP94, HSP82, HSP90, HTPG, CHAPERONE, LIGAND, RADICICOL, KEYWDS 2 GELDANAMYCIN, RADESTER, RADAMIDE EXPDTA X-RAY DIFFRACTION AUTHOR R.M.IMMORMINO,D.T.GEWIRTH REVDAT 4 30-AUG-23 2FYP 1 REMARK SEQADV REVDAT 3 02-AUG-17 2FYP 1 SOURCE REVDAT 2 24-FEB-09 2FYP 1 VERSN REVDAT 1 06-FEB-07 2FYP 0 JRNL AUTH R.M.IMMORMINO,D.T.GEWIRTH,B.S.BLAGG JRNL TITL INHIBITTORY LIGANDS ADOPT DIFFERENT CONFORMATIONS WHEN BOUND JRNL TITL 2 TO HSP90 OR GRP94: IMPLICATIONS FOR PARALOG-SPECIFIC DRUG JRNL TITL 3 DESIGN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2199486.390 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 38680 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3904 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5331 REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 582 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3533 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 126 REMARK 3 SOLVENT ATOMS : 365 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.79000 REMARK 3 B22 (A**2) : -2.74000 REMARK 3 B33 (A**2) : 8.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.440 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.330 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.250 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.140 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 56.13 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : 1PE_XPLOR_PARAM.PARAM REMARK 3 PARAMETER FILE 4 : PG4_XPLOR_PARAM.PARAM REMARK 3 PARAMETER FILE 5 : NO_QUINONE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : 1PE_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 4 : PG4_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 5 : NO_QUINONE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 42 REMARK 42 MOLPROBITY STRUCTURE VALIDATION REMARK 42 PROGRAMS : MOLPROBITY (KING, REDUCE, AND PROBE) REMARK 42 AUTHORS : I.W.DAVIS,J.M.WORD REMARK 42 URL : HTTP://KINEMAGE.BIOCHEM.DUKE.EDU/MOLPROBITY/ REMARK 42 AUTHORS : J.S.RICHARDSON,W.B.ARENDALL,D.C.RICHARDSON REMARK 42 REFERENCE : NEW TOOLS AND DATA FOR IMPROVING REMARK 42 : STRUCTURES, USING ALL-ATOM CONTACTS REMARK 42 : METHODS IN ENZYMOLOGY. 2003;374:385-412. REMARK 42 MOLPROBITY OUTPUT SCORES: REMARK 42 ALL-ATOM CLASHSCORE : 9.31 (7.22 B<40) REMARK 42 BAD ROTAMERS : 0.0% 0/373 (TARGET 0-1%) REMARK 42 RAMACHANDRAN OUTLIERS : 0.0% 0/456 (TARGET 0.2%) REMARK 42 RAMACHANDRAN FAVORED : 95.6% 436/456 (TARGET 98.0%) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036469. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SAGITAL CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38680 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.29100 REMARK 200 FOR SHELL : 4.270 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YT1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8.0, 25-30% PEG MME REMARK 280 550, 10-50 MM MGCL2, .5-1UL LIGAND (IN DMSO) PER 50 PROTEIN FOR REMARK 280 FINAL CONCENTRATION ~5-10MM , VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.54000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.37000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.54000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.80500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.37000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: EACH PROTOMER IN THE ASYMMETRICT UNIT COMPRISES AN ASSUMED REMARK 300 BIOLOGICAL MOLECULE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 324 REMARK 465 GLY A 325 REMARK 465 GLY A 326 REMARK 465 GLY A 327 REMARK 465 GLY B 324 REMARK 465 GLY B 325 REMARK 465 GLY B 326 REMARK 465 GLY B 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 TYR A 94 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 GLU A 130 CG CD OE1 OE2 REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 SER A 169 OG REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 LEU A 175 CG CD1 CD2 REMARK 470 ASN A 176 CG OD1 ND2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 GLN A 182 CG CD OE1 NE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ASP A 184 CG OD1 OD2 REMARK 470 GLN A 186 CG CD OE1 NE2 REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 PHE A 274 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 328 CG CD CE NZ REMARK 470 LYS B 72 CG CD CE NZ REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 GLU B 123 CG CD OE1 OE2 REMARK 470 LYS B 140 CG CD CE NZ REMARK 470 GLU B 141 CG CD OE1 OE2 REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 LYS B 161 CG CD CE NZ REMARK 470 LYS B 168 CG CD CE NZ REMARK 470 SER B 169 OG REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 GLU B 180 CG CD OE1 OE2 REMARK 470 GLU B 183 CG CD OE1 OE2 REMARK 470 ASP B 184 CG OD1 OD2 REMARK 470 GLN B 186 CG CD OE1 NE2 REMARK 470 GLU B 190 CG CD OE1 OE2 REMARK 470 GLN B 194 CG CD OE1 NE2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 LYS B 328 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 73 5.69 -69.17 REMARK 500 ASN A 129 118.06 -167.52 REMARK 500 THR A 150 40.67 -103.00 REMARK 500 ALA A 167 -114.99 -128.50 REMARK 500 LYS A 168 -1.79 67.11 REMARK 500 SER A 169 17.35 51.42 REMARK 500 SER A 227 -13.03 86.70 REMARK 500 GLU A 229 176.50 172.56 REMARK 500 ASN B 129 113.00 -174.20 REMARK 500 ALA B 167 -109.11 -123.11 REMARK 500 LYS B 168 -6.90 62.76 REMARK 500 SER B 169 19.20 54.50 REMARK 500 SER B 227 -10.25 87.19 REMARK 500 GLU B 229 173.80 176.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 ONLY FRAGMENTS OF PEG400 WERE IDENTIFIED AND IN REMARK 600 MANY CASES SEVERAL ATOMS WERE MISSING DUE TO LACK OF REMARK 600 ELECTRON DENSITY. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 RDE A 1001 REMARK 610 PG4 A 501 REMARK 610 PG4 A 503 REMARK 610 PG4 A 508 REMARK 610 RDE B 1002 REMARK 610 PG4 B 506 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RDE A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RDE B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PE B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZWH RELATED DB: PDB REMARK 900 YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE REMARK 900 RELATED ID: 2FXS RELATED DB: PDB REMARK 900 YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADAMIDE REMARK 900 RELATED ID: 1QY8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 REMARK 900 IN COMPLEX WITH RADICICOL REMARK 900 RELATED ID: 1U0Z RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH REMARK 900 RADICICOL REMARK 900 RELATED ID: 2EXL RELATED DB: PDB REMARK 900 GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN REMARK 900 RELATED ID: 1YET RELATED DB: PDB REMARK 900 GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING DOMAIN REMARK 900 RELATED ID: 1BGQ RELATED DB: PDB REMARK 900 RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF REMARK 900 THE YEAST HSP90 CHAPERONE REMARK 900 RELATED ID: 1OSF RELATED DB: PDB REMARK 900 HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N, N- REMARK 900 DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE DATABASE RESIDUES 287-327 WERE DELETED REMARK 999 AND REPLACED BY 4 GLYCINES. DBREF 2FYP A 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2FYP A 328 337 UNP P41148 ENPL_CANFA 328 337 DBREF 2FYP B 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2FYP B 328 337 UNP P41148 ENPL_CANFA 328 337 SEQADV 2FYP GLY A 65 UNP P41148 CLONING ARTIFACT SEQADV 2FYP SER A 66 UNP P41148 CLONING ARTIFACT SEQADV 2FYP HIS A 67 UNP P41148 CLONING ARTIFACT SEQADV 2FYP MET A 68 UNP P41148 CLONING ARTIFACT SEQADV 2FYP GLY A 324 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY A 325 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY A 326 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY A 327 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY B 65 UNP P41148 CLONING ARTIFACT SEQADV 2FYP SER B 66 UNP P41148 CLONING ARTIFACT SEQADV 2FYP HIS B 67 UNP P41148 CLONING ARTIFACT SEQADV 2FYP MET B 68 UNP P41148 CLONING ARTIFACT SEQADV 2FYP GLY B 324 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY B 325 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY B 326 UNP P41148 SEE REMARK 999 SEQADV 2FYP GLY B 327 UNP P41148 SEE REMARK 999 SEQRES 1 A 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 A 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 A 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 A 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 A 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 A 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 A 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 A 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 A 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 A 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 A 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 A 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 A 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 A 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 A 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 A 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 A 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 A 236 MET ASN SEQRES 1 B 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 B 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 B 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 B 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 B 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 B 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 B 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 B 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 B 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 B 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 B 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 B 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 B 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 B 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 B 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 B 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 B 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 B 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 B 236 MET ASN HET RDE A1001 12 HET PG4 A 501 10 HET PG4 A 502 13 HET PG4 A 503 10 HET PG4 A 508 7 HET RDE B1002 12 HET PG4 B 504 13 HET PG4 B 505 13 HET PG4 B 506 7 HET PG4 B 507 13 HET 1PE B 601 16 HETNAM RDE 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4- HETNAM 2 RDE DIHYDROXYBENZOATE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN 1PE PEG400 FORMUL 3 RDE 2(C18 H20 CL N O7) FORMUL 4 PG4 8(C8 H18 O5) FORMUL 13 1PE C10 H22 O6 FORMUL 14 HOH *365(H2 O) HELIX 1 1 SER A 66 GLU A 71 1 6 HELIX 2 2 GLN A 79 LEU A 93 1 15 HELIX 3 3 GLU A 98 ASP A 122 1 25 HELIX 4 4 THR A 155 THR A 165 1 11 HELIX 5 5 GLY A 170 ALA A 181 1 12 HELIX 6 6 THR A 188 PHE A 195 1 8 HELIX 7 7 VAL A 197 LEU A 204 5 8 HELIX 8 8 GLU A 253 LEU A 259 5 7 HELIX 9 9 GLU A 260 GLN A 273 1 14 HELIX 10 10 SER B 66 LYS B 72 1 7 HELIX 11 11 GLN B 79 LEU B 93 1 15 HELIX 12 12 GLU B 98 ASP B 122 1 25 HELIX 13 13 THR B 155 THR B 165 1 11 HELIX 14 14 GLY B 170 GLY B 185 1 16 HELIX 15 15 THR B 188 GLY B 196 1 9 HELIX 16 16 VAL B 197 LEU B 204 5 8 HELIX 17 17 GLU B 253 LEU B 259 5 7 HELIX 18 18 GLU B 260 GLN B 273 1 14 SHEET 1 A 9 LYS A 75 PHE A 76 0 SHEET 2 A 9 PHE A 230 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N LEU A 145 O LEU A 249 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N ASP A 139 O LEU A 144 SHEET 8 A 9 ILE A 279 LYS A 285 1 O TRP A 282 N ILE A 136 SHEET 9 A 9 VAL A 330 LEU A 335 -1 O VAL A 330 N LYS A 285 SHEET 1 B 9 LYS B 75 PHE B 76 0 SHEET 2 B 9 PHE B 230 ALA B 234 -1 O PHE B 230 N PHE B 76 SHEET 3 B 9 HIS B 221 SER B 225 -1 N ILE B 222 O ILE B 233 SHEET 4 B 9 ALA B 206 LYS B 214 -1 N VAL B 211 O TRP B 223 SHEET 5 B 9 GLY B 244 LEU B 251 -1 O THR B 248 N ILE B 210 SHEET 6 B 9 LEU B 144 ASP B 149 -1 N LEU B 145 O LEU B 249 SHEET 7 B 9 VAL B 134 ASP B 139 -1 N LYS B 135 O THR B 148 SHEET 8 B 9 ILE B 279 LYS B 285 1 O TYR B 280 N ILE B 136 SHEET 9 B 9 VAL B 330 LEU B 335 -1 O ASP B 332 N SER B 283 SITE 1 AC1 9 ASN A 107 ALA A 111 ASP A 149 MET A 154 SITE 2 AC1 9 PHE A 199 THR A 245 ILE A 247 HOH A1005 SITE 3 AC1 9 HOH A1006 SITE 1 AC2 10 ASN B 107 ALA B 111 ASP B 149 GLY B 153 SITE 2 AC2 10 MET B 154 PHE B 199 THR B 245 ILE B 247 SITE 3 AC2 10 HOH B1007 HOH B1009 SITE 1 AC3 4 THR A 212 ARG A 237 THR A 248 HOH A1178 SITE 1 AC4 5 LYS A 137 THR A 148 TRP A 282 HOH A1097 SITE 2 AC4 5 HOH A1170 SITE 1 AC5 4 ASP A 110 LYS A 114 LEU A 117 HOH A1168 SITE 1 AC6 5 THR B 212 ARG B 237 THR B 240 THR B 248 SITE 2 AC6 5 HOH B1024 SITE 1 AC7 7 LYS B 137 HIS B 146 THR B 148 TRP B 282 SITE 2 AC7 7 HOH B1003 HOH B1125 HOH B1151 SITE 1 AC8 2 ASP B 262 ASN B 266 SITE 1 AC9 3 ASP B 110 LYS B 114 LEU B 117 SITE 1 BC1 4 GLY A 128 ASN A 129 ASN A 239 HOH A1048 SITE 1 BC2 10 ASN A 83 LYS A 87 SER A 227 HOH A1060 SITE 2 BC2 10 ASN B 83 LYS B 87 ILE B 90 SER B 227 SITE 3 BC2 10 HOH B1157 HOH B1168 CRYST1 65.610 84.740 95.080 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015242 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011801 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010517 0.00000